Related Experiment Video
Updated: Oct 17, 2025

Author Spotlight: Advancing Therapeutics to Treat Vibriosis in Humans and Aquatic Organisms
Published on: May 31, 2024
Systemic quinolones and risk of retinal detachment I: analysis of data from the US FDA adverse event reporting system
Mohamed Kadry Taher1,2,3, Abdallah Alami3, Christopher A Gravel1,2,4
1McLaughlin Centre for Population Health Risk Assessment, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
Background:
Quinolones comprise a class of antibiotics that are globally preferred for treating a wide range of bacterial infections due to their potency, broad coverage, favorable pharmacologic profile, and mostly mild to moderate adverse reactions. Spontaneous reports on adverse drug events (ADE) and data from some pharmacoepidemiologic studies have raised concerns regarding quinolones and risk of retinal detachment (RD). This study examined ADE reports submitted to FDA adverse event reporting system (FAERS) for evidence on quinolone-associated RD risk.
Research Design And Methods:
We identified all RD reports in FAERS between 2010-2019. We compared ADE signals between quinolones and selected medications that were previously associated with RD, and with reference medications not known to cause RD. For signal detection, we used two techniques: the proportional reporting ratio (PRR) and multi-item gamma Poisson shrinker (MGPS), which are known for their higher sensitivity and specificity for ADE signal detection, respectively.
Results:
Moxifloxacin showed a positive and significant PRR signal for RD [PRR: 2.54 (1.60, 4.04)], and a marginally significant EBGM signal [EBGM: 2.21 (1.41, 3.02)].
Conclusion:
Moxifloxacin is the only quinolone showing a positive disproportionality signal for RD. Further epidemiologic research is needed to clarify the association between moxifloxacin and RD risk.
Insights
Moxifloxacin, a quinolone antibiotic, showed a potential link to retinal detachment (RD) in a safety analysis. Further research is needed to confirm this association and understand the risks of quinolone use.
Area of Science:
- Pharmacovigilance and Drug Safety
- Ophthalmology
- Infectious Diseases
Background:
- Quinolones are widely used antibiotics with a generally favorable safety profile.
- Concerns exist regarding a potential association between quinolone use and retinal detachment (RD).
- This study investigated adverse drug event (ADE) reports to assess quinolone-associated RD risk.
Purpose of the Study:
- To evaluate the association between quinolone antibiotics and the risk of retinal detachment (RD).
- To analyze spontaneous adverse drug event (ADE) reports for signals of quinolone-associated RD.
Main Methods:
- Retrospective analysis of retinal detachment (RD) reports in the FDA Adverse Event Reporting System (FAERS) from 2010-2019.
- Utilized proportional reporting ratio (PRR) and multi-item gamma Poisson shrinker (MGPS) for ADE signal detection.
- Compared quinolone ADE signals against medications with known and unknown associations with RD.
Main Results:
- Moxifloxacin demonstrated a significant positive proportional reporting ratio (PRR) signal for RD (PRR: 2.54).
- A marginally significant Empirical Bayes Geometric Mean (EBGM) signal was also observed for moxifloxacin and RD (EBGM: 2.21).
- No other quinolone showed a significant disproportionality signal for RD.
Conclusions:
- Moxifloxacin emerged as the sole quinolone exhibiting a positive signal for RD in this analysis.
- The findings suggest a potential association between moxifloxacin and an increased risk of retinal detachment.
- Further epidemiological studies are warranted to definitively establish the relationship between moxifloxacin and RD risk.
More Related Videos
05:03Author Spotlight: Investigating Physiological Functions of Vitamin A Transporters Using HPLC-Based Vitamin A Profiling
Published on: December 27, 2024
06:19Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology
Published on: May 31, 2024
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Gene Regulation in Microbial Communities: Quorum Sensing
Oxidation of Phenols to Quinones
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Drug Regulation